A Phase II study of selinexor plus cytarabine and idarubicin in patients with relapsed/refractory acute myeloid leukaemia.

BRITISH JOURNAL OF HAEMATOLOGY(2020)

引用 12|浏览1
暂无评分
关键词
acute myeloid leukaemia,clinical studies,chemotherapy,selinexor
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要